1
|
Cuello JF, Bardach A, Gromadzyn G, Ruiz Johnson A, Comandé D, Aguirre E, Ruvinsky S. Neurosurgical simulation models developed in Latin America and the Caribbean: a scoping review. Neurosurg Rev 2023; 47:24. [PMID: 38159156 DOI: 10.1007/s10143-023-02263-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 12/16/2023] [Accepted: 12/24/2023] [Indexed: 01/03/2024]
Abstract
Simulation training is an educational tool that provides technical and cognitive proficiency in a risk-free environment. Several models have recently been presented in Latin America and the Caribbean (LAC). However, many of them were presented in non-indexed literature and not included in international reviews. This scoping review aims to describe the simulation models developed in LAC for neurosurgery training. Specifically, it focuses on assessing the models developed in LAC, the simulated neurosurgical procedures, the model's manufacturing costs, and the translational outcomes. Simulation models developed in LAC were considered, with no language or time restriction. Cadaveric, ex vivo, animal, synthetic, and virtual/augmented reality models were included for cranial and spinal procedures. We conducted a review according to the PRISMA-ScR, including international and regional reports from indexed and non-indexed literature. Two independent reviewers screened articles. Conflicts were resolved by a third reviewer using Covidence software. We collected data regarding the country of origin, recreated procedure, type of model, model validity, and manufacturing costs. Upon screening 917 studies, 69 models were developed in LAC. Most of them were developed in Brazil (49.28%). The most common procedures were related to general neurosurgery (20.29%), spine (17.39%), and ventricular neuroendoscopy and cerebrovascular (15.94% both). Synthetic models were the most frequent ones (38.98%). The manufacturing cost ranged from 4.00 to 2005.00 US Dollars. To our knowledge, this is the first scoping review about simulation models in LAC, setting the basis for future research studies. It depicts an increasing number of simulation models in the region, allowing a wide range of neurosurgical training in a resource-limited setting.
Collapse
Affiliation(s)
| | - Ariel Bardach
- Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina
- Centro de Investigaciones Epidemiológicas y Salud Pública (CIESP-IECS), CONICET, Buenos Aires, Argentina
| | - Guido Gromadzyn
- Neurosurgery Department, Hospital Garrahan, Buenos Aires, Argentina
| | | | - Daniel Comandé
- Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina
| | - Emilio Aguirre
- Neurosurgery Department, Hospital Cordero, San Fernando, Argentina
| | | |
Collapse
|
2
|
Andres R, Hernandez A, Fernandez A, Comin A, Nuño A, Aguirre E, Arevalo E, Millastre E, Alvarez I, Verdun J, Lao J, Murillo L, Galan N, Bueso P, Puertolas T, Hagen C, Inglada-Perez L, Anton A. P158 PONDx Aragon: First spanish prospective study evaluating the impact of the 21-gene test on real praxis for N1 patients after RxPONDER results. Breast 2023. [DOI: 10.1016/s0960-9776(23)00275-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/15/2023] Open
|
3
|
Huamán L, Huincho S, Aguirre E, Rodriguez G, Brandolini A, Hidalgo A. Physico-chemical characteristics and oxidative stability of oils from different Peruvian castor bean ecotypes. grasasaceites 2022. [DOI: 10.3989/gya.1016202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The aim of this research was to assess the physico-chemical properties and shelf-life of oils press-extracted at two temperatures (60 °C and 80 °C) from five Peruvian castor bean ecotypes. A wide variation for all traits was observed. Low acidity index, low peroxide index and absence of p-anisidine were recorded. The total tocopherol contents ranged from 798 to 1040 mg/kg. A higher antioxidant capacity was detected in methanolic extracts than in hexane extract. From the Rancimat performed at 150-170 °C, the predicted shelf-life at 25 °C ranged from 0.15 to 8.93 years; the higher extraction temperature led to a longer shelf-life, probably because of enzyme inactivation.
Collapse
|
4
|
Jeyanathan M, Fritz DK, Afkhami S, Aguirre E, Howie KJ, Zganiacz A, Dvorkin-Gheva A, Thompson MR, Silver R, Cusack RP, Lichty BD, O'Byrne PM, Kolb M, Medina MFC, Dolovich MB, Satia I, Gauvreau GM, Xing Z, Smaill F. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans. JCI Insight 2022; 7:155655. [PMID: 34990408 PMCID: PMC8855837 DOI: 10.1172/jci.insight.155655] [Citation(s) in RCA: 41] [Impact Index Per Article: 20.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Accepted: 12/16/2021] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Adenoviral (Ad)-vectored vaccines are typically administered via intramuscular injection to humans, incapable of inducing respiratory mucosal immunity. However, aerosol delivery of Ad-vectored vaccines remains poorly characterized and its ability to induce mucosal immunity in humans is unknown. This phase 1b trial was to evaluate the safety and immunogenicity of human serotype-5 Ad-vectored tuberculosis (TB) vaccine (AdHu5Ag85A) delivered to humans via inhaled aerosol or intramuscular injection. METHODS 31 healthy, previously BCG-vaccinated adults were enrolled. AdHu5Ag85A was administered by single-dose aerosol using Aeroneb® Solo Nebulizer or by intramuscular (IM) injection. The study consisted of the low dose (LD) aerosol, high dose (HD) aerosol and IM groups. The adverse events were assessed at various times post-vaccination. Immunogenicity data were collected from the peripheral blood and bronchoalveolar lavage samples at baseline and select timepoints post-vaccination. RESULTS The nebulized aerosol droplets were <5.39µm in size. Both LD and HD of AdHu5Ag85A administered by aerosol inhalation and IM injection were safe and well-tolerated. Both aerosol doses, particularly LD, but not IM, vaccination markedly induced airway tissue-resident memory CD4 and CD8 T cells of polyfunctionality. While as expected, IM vaccination induced Ag85A-specific T cell responses in the blood, the LD aerosol vaccination also elicited such T cells in the blood. Furthermore, the LD aerosol vaccination induced persisting transcriptional changes in alveolar macrophages. CONCLUSIONS Inhaled aerosol delivery of Ad-vectored vaccine is a safe and superior way to elicit respiratory mucosal immunity. This study warrants further development of aerosol vaccine strategies against respiratory pathogens including TB and COVID-19. TRIAL REGISTRATION This trial is registered with ClinicalTrial.gov, NCT# 02337270. FUNDING The Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council of Canada.
Collapse
Affiliation(s)
| | - Dominik K Fritz
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Sam Afkhami
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Emilio Aguirre
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
| | - Karen J Howie
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Anna Zganiacz
- Department of Medicine, McMaster University, Hamilton, Canada
| | | | - Michael R Thompson
- Department of Chemical Engineering, McMaster University, Hamilton, Canada
| | - Richard Silver
- Department of Critical Care Medicine and Sleep Medicine, Case Western Researve University, Cleveland, United States of America
| | - Ruth P Cusack
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Brian D Lichty
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Paul M O'Byrne
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Martin Kolb
- Department of Medicine, McMaster University, Hamilton, Canada
| | | | | | - Imran Satia
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Gail M Gauvreau
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Zhou Xing
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Fiona Smaill
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
| |
Collapse
|
5
|
González-Santiago S, Ramón y Cajal T, Aguirre E, Alés-Martínez JE, Andrés R, Balmaña J, Graña B, Herrero A, Llort G, González-del-Alba A. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol 2019; 22:193-200. [DOI: 10.1007/s12094-019-02262-0] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 12/05/2019] [Indexed: 12/17/2022]
Abstract
AbstractMutations in BRCA1 and BRCA2 high penetrance genes account for most hereditary breast and ovarian cancer, although other new high-moderate penetrance genes included in multigene panels have increased the genetic diagnosis of hereditary breast and ovarian cancer families by 50%. Multigene cancer panels provide new challenges related to increased frequency of variants of uncertain significance, new gene-specific cancer risk assessments, and clinical recommendations for carriers of mutations of new genes. Although clinical criteria for genetic testing continue to be largely based on personal and family history with around a 10% detection rate, broader criteria are being applied with a lower threshold for detecting mutations when there are therapeutic implications for patients with breast or ovarian cancer. In this regard, new models of genetic counselling and testing are being implemented following the registration of PARP inhibitors for individuals who display BRCA mutations. Massive sequencing techniques in tumor tissue is also driving a paradigm shift in genetic testing and potential identification of germline mutations. In this paper, we review the current clinical criteria for genetic testing, as well as surveillance recommendations in healthy carriers, risk reduction surgical options, and new treatment strategies in breast cancer gene-mutated carriers.
Collapse
|
6
|
Daquarti G, Sanabria H, Rosa D, Cornelli M, Gobbo M, Rapallo C, Vera M, Aguirre E, Coronel D, Blanco N, Perez Balino N, Masoli O, Meretta A. P389Microvascular dysfunction in type 2 diabetic patients with normal rest-stress myocardial perfusion imaging. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez149.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G Daquarti
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - H Sanabria
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - D Rosa
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - M Cornelli
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - M Gobbo
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - C Rapallo
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - M Vera
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - E Aguirre
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - D Coronel
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - N Blanco
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - N Perez Balino
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - O Masoli
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - A Meretta
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| |
Collapse
|
7
|
Manso L, Bermejo B, Delgado I, Aguirre E, Oltra A, Gonzalez M, Malón D, Ales J, Rodriguez C, Moreno F. PALBOCOMP: Retrospective observational analysis of palbociclib treatment in patients with advanced breast cancer within a compassionate use program in Spain. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz100.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Blancas I, Aguirre E, Morales S, Gonzálvez ML, Servitja S, Díaz N, Del Barco S, Barnadas A, Margelí M, García Carbonero I, Llombart A. Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens. Clin Transl Oncol 2018; 21:459-466. [PMID: 30293232 DOI: 10.1007/s12094-018-1946-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Accepted: 09/05/2018] [Indexed: 01/29/2023]
Abstract
PURPOSE To evaluate the efficacy and safety of oral weekly vinorelbine 60 mg/m2 for metastatic breast cancer (MBC) in patients previously treated with anthracyclines or taxanes in routine clinical practice. MATERIALS AND METHODS Fifty-five patients were enrolled in a prospective multicentre study conducted in Spain. Women ≥ 18 years of age with locally advanced breast cancer who were not candidates for surgical treatment with a radical intention or patients with stage IV disease, and who had received a prior taxane or anthracycline regimen were eligible for participation. RESULTS Median age was 67 years. Median progression-free survival was 3.7 months (95% CI 2.5-4.9), median overall survival 10 months (95% CI 6.6-13.5), and overall response rate and clinical benefit rate were 29.1% and 49.1%, respectively. Main grade 3 and 4 toxicities were neutropenia 9.1%, febrile neutropenia 3.6% and constipation 3.6%. In total, 86% of the patients received complete treatment without delays or dose reduction. Moreover, HER2-positive patients who received oral vinorelbine concomitantly with trastuzumab showed better response (complete response: HER2-positive 14.3% vs. HER2-negative 0%; partial response: HER2-positive 42.9% vs. HER2-negative 25.6%; p = 0.008), better disease control rate (HER2-positive 100% vs. HER2-negative 46.2%; p = 0.011), and better values for the remaining analysed variables than HER2-negative patients. CONCLUSION Our study provides real-world data on the use of oral weekly vinorelbine, which proves an effective and well-tolerated regimen for MBC patients previously treated with taxanes or anthracyclines. Patients with HER2-positive disease could also benefit from this treatment in combination with trastuzumab.
Collapse
Affiliation(s)
- I Blancas
- Department of Medical Oncology, University Hospital San Cecilio, Av. De la Investigación s/n, 18016, Granada, Spain.
| | - E Aguirre
- Department of Medical Oncology, University Hospital Arnau de Vilanova, Lleida, Spain
| | - S Morales
- Department of Medical Oncology, University Hospital Arnau de Vilanova, Lleida, Spain
| | - M L Gonzálvez
- Department of Medical Oncology, University Hospital Arrixaca, Murcia, Spain
| | - S Servitja
- Department of Medical Oncology, Hospital Del Mar, Barcelona, Spain
| | - N Díaz
- Department of Medical Oncology, University Hospital San Juan de Alicante, Alicante, Spain
| | - S Del Barco
- Department of Medical Oncology, Institut Català d'Oncologia, Girona, Spain
| | - A Barnadas
- Department of Medical Oncology, University Hospital Sant Pau, Barcelona, Spain
| | - M Margelí
- Department of Medical Oncology, Institut Català d'Oncologia, Badalona, Spain
| | - I García Carbonero
- Department of Medical Oncology, Virgen de La Salud Hospital, Toledo, Spain
| | - A Llombart
- Department of Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain
| |
Collapse
|
9
|
López-Miranda E, Brain E, Saura C, Gligorov J, Dubot C, Dieras V, Suter TM, Aguirre E, Perez-García JM, Llombart A, Cortés J. Abstract OT1-02-03: Phase I multicenter clinical trial evaluating the combination of trastuzumab emtansine (T-DM1) and non-pegylated liposomal doxorubicin (NPLD) in HER2-positive metastatic breast cancer (MBC) (MEDOPP038 study). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-ot1-02-03] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND:
Clinical efficacy and safety of T-DM1 for the treatment of HER2-positive MBC has been assessed in several phase II and III trials and is now considered the standard of care in taxane-and trastuzumab-progressing patients. However, although T-DM1 has shown encouraging antitumor activity in the advanced setting, several strategies to improve T-DM1 efficacy are currently evaluated, including the combination with non-pegylated liposomal doxorubicin (NPLD), considering that: i) doxorubicin is one of the most active chemotherapeutic agents against HER2-positive breast cancer; ii) the combination of doxorubicin and trastuzumab induces synergistic antitumor activity in HER2-overexpressing preclinical models; and iii) liposomal formulations of doxorubicin have a reduced risk of developing cardiac toxicity.
OBJECTIVES:
The primary objective of this trial is to determine the maximum tolerated dose (MTD) of the combination of T-DM1 and NPLD in patients with HER2-positive MBC naïve of anthracyclines and previously treated with trastuzumab and a taxane. The secondary objectives include 1) safety, with special emphasis on cardiac safety evaluated by left ventricular ejection fraction, high-sensitivity troponin I and B-type natriuretic peptide (BNP) levels, 2) pharmacokinetics, 3) antitumor activity, and the 4) role of single nucleotide polymorphisms of HER2 gene for developing cardiotoxicity.
TRIAL DESIGN:
This is a dose-finding, open-label, non-randomized and multicenter phase I clinical trial of T-DM1 at a fixed dose of 3.6 mg/kg IV in combination with three different dose levels (DL) of NPLD (45, 50, and 60 mg/m2) IV administered on Day 1 every three weeks. The trial follows a modified dose escalation scheme with a 3+3 design.A total of three patients will be included in the first cohort and observed for dose-limiting toxicities (DLTs) during the first two cycles of treatment. If none of these patients experiences a DLT, three other patients will be treated at the next DL. However, in case of at least one patient experiences a DLT, three more patients will be treated at the same DL. The MTD will be defined as the highest DL at which ≤1 of six patients experiences a DLT during the first two cycles of treatment. An expansion cohort of six additional patients at the MTD will be included.
ELIGIBILITY:
Anthracycline-naïve patients with HER2-positive MBC and up to two prior chemotherapy regimens in the advanced setting who previously were treated with trastuzumab and a taxane. ECOG performance status of 0-1. Adequate organ and cardiovascular function with LVEF ≥ 55%. RECIST v1.1 evaluable disease.
ACCRUAL:
A total of 12-24 patients will be enrolled at four sites in Spain and France. Recruitment was opened on September 2015. To date, four patients (three at DL1 and one at DL2) have been recruited.
Citation Format: López-Miranda E, Brain E, Saura C, Gligorov J, Dubot C, Dieras V, Suter TM, Aguirre E, Perez-García JM, Llombart A, Cortés J. Phase I multicenter clinical trial evaluating the combination of trastuzumab emtansine (T-DM1) and non-pegylated liposomal doxorubicin (NPLD) in HER2-positive metastatic breast cancer (MBC) (MEDOPP038 study) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr OT1-02-03.
Collapse
Affiliation(s)
- E López-Miranda
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - E Brain
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - C Saura
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - J Gligorov
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - C Dubot
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - V Dieras
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - TM Suter
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - E Aguirre
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - JM Perez-García
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - A Llombart
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| | - J Cortés
- Ramón y Cajal University Hospital, Madrid, Spain; Institut Curie / Hôpital René Huguenin, St Cloud, France; Vall d´Hebrón University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain; APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France; Institut Curie, Paris, France; Bern University Hospital, Cardiology, Bern, Switzerland; Medica Scientia Innovation Research – MedSIR ARO, Barcelona, Spain; Baselga Institute of Oncology, Quiron University Hospital, Barcelona, Spain; Hospital Arnau i Vilanova, Valencia, Spain
| |
Collapse
|
10
|
Aguirre E, Mele M, Tuset N, Velasco A, Tarragona J, Sampayo M, Serrano S, Riu F, Rodriguez-Balada M, Matias-Guiu X, Garcia E, Ortega E, BalmaÑa J. Screening for Lynch syndrome among endometrial cancer patients less than 60 years. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw374.34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Ortega V, Lao J, Garau I, Afonso N, Calvo L, Fernández Y, Martinez-Garcia M, Blanco E, Zamora P, García M, Illarramendi J, Rodríguez C, Aguirre E, Pérez J, Castan JC, Llombart-Cussac A. MERIBEL study: Single-agent eribulin as first-line therapy for taxane-resistant HER2[-] metastatic breast cancer (MBC) patients (pts). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw365.17] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Martins Fernandes S, Badano L, Garcia Campos A, Erdei T, Mehdipoor G, Hanboly N, Michalski BW, Vriz O, Mo VY, Le TT, Ribeiro JM, Ternacle J, Yurdakul SELEN, Shetye A, Stoebe S, Lisowska A, Chinali M, Orabona M, Contaldi C, De La Chica JA, Codolosa JN, Trzcinski P, Prado Diaz S, Morales Portano JD, Ha SJ, Valente F, Joseph G, Valente F, Scali MC, Cordeiro F, Duchateau N, Fabris E, Costantino MF, Cho IJ, Goublaire C, Lam W, Galli E, Kim KH, Mariani M, Malev E, Zuercher F, Tang Z, Cimino S, Mahia P, De La Chica JA, Petrovic J, Ciobotaru V, Remsey- Semmelweiss E, Kogoj P, Guerreiro S, Saxena A, Mozenska O, Pontone G, Macaya Ten F, Caballero L, Avegliano G, Halmai L, Reis L, Trifunovic D, Gospodinova M, Makavos G, D'ascenzi F, Dantas Tavares De Melo M, Bonapace S, Kulkarni A, Cameli M, Ingvarsson A, Driessen MMP, Tufekcioglu O, Radulescu D, Barac A, Cioffi G, Almeida Morais L, Ledakowicz-Polak A, Portugal G, Naksuk N, Parato VM, Kovalova S, Cherubini A, Corrado G, Malev E, Wierzbowska-Drabik K, Lesevic H, Laredj N, Pieles GE, Generati G, Van Zalen JJ, Aquila I, Cheng HL, Lanzoni L, Asmarats Serra L, Kadrabulatova S, Ranjbar S, Szczesniak-Stanczyk D, Sharka I, Di Salvo G, Ben Kahla S, Li L, Hadeed HA, Habeeb HA, Toscano A, Granata F, Djikic D, Wdowiak-Okrojek K, Girgis HYA, Sharma A, Soro C, Gallego Page JC, Corneli M, Teixeira R, Roussin I, Lynch M, Muraru D, Romeo G, Ermacora D, Marotta C, Aruta P, Cucchini U, Iliceto S, Martin-Fernandez M, De La Hera Galarza JM, Corros-Vicente C, Colunga Blanco S, Velasco-Alonso E, Leon-Aguero V, Rodriguez-Suarez ML, Moris De La Tassa C, Edwards J, Braim D, Price C, Fraser AG, Salmani F, Arjmand Shabestari A, Szymczyk E, Kupczynska K, Peczek L, Nawrot B, Lipiec P, Kasprzak JD, Driussi C, Ferrara F, Brosolo G, Antonini-Canterin F, Magne J, Aboyans V, Bossone E, Bellucci BM, Fisher JM, Balekian AA, Idapalapati S, Huang F, Wong JI, Tan RS, Teixeira R, Madeira M, Almeida I, Reis L, Siserman A, Dinis P, Dias L, Ramos AP, Goncalves L, Wan FW, Sawaki DS, Dubois-Rande JLDR, Adnot SA, Czibik GC, Derumeaux GD, Ercan G, Tekkesin ILKER, Sahin ST, Cengiz B, Celik G, Demircan S, Aytekin SAIDE, Razvi NA, Nazir SA, Price N, Khan JN, Kanagala P, Singh A, Squire I, Mccann GP, Langel M, Pfeiffer D, Hagendorff A, Ptaszynska-Kopczynska K, Marcinkiewicz-Siemion M, Knapp M, Witkowski M, Musial WJ, Kaminski K, Natali B, D' Anna C, Leonardi B, Secinaro A, Pongiglione G, Rinelli G, Renard S, Michel N, Mancini J, Haentjens J, Sitbon O, Habib G, Imbriaco M, Alcidi G, Santoro C, Buonauro A, Lo Iudice F, Lembo M, Cuocolo A, Trimarco B, Galderisi M, Mora Robles J, Roldan Jimenez MA, Mancisidor MA, De Mora MA, Alnabelsi T, Goykhman I, Koshkelashvili N, Romero-Corral A, Pressman GS, Michalski BW, Kupczynska K, Miskowiec D, Lipiec P, Kasprzak JD, Montoro Lopez N, Refoyo Salicio E, Valbuena Lopez SC, Gonzalez O, Alvarez C, Moreno Yanguela M, Bartha Rasero JL, De La Calle M, Guzman Martinez G, Suarez-Cuenca JA, Merino JA, Gomez Alvarez EB, Delgado LG, Woo YM, Bang WD, Sohn GH, Cheong SS, Yoo SY, Rodriguez Palomares JF, Gutierrez L, Maldonado G, Pineda V, Galian L, Teixido G, Gonzalez Allujas MT, Evangelista A, Garcia Dorado D, Zaremba T, Ekeloef S, Heiberg E, Engblom H, Jensen SE, Sogaard P, Rodriguez Palomares JF, Gutierrez L, Garcia G, Pineda V, Galian L, Teixido G, Gonzalez Allujas MT, Evangelista A, Garcia Dorado D, Dini FL, Galli F, Lattanzi F, Picano E, Marzilli M, Leao S, Moz M, Magalhaes P, Trigo J, Mateus PS, Ferreira A, Moreira JI, De Craene M, Legallois D, Labombarda F, Pellissier A, Sermesant M, Saloux E, Merlo M, Moretti M, Barbati G, Stolfo D, Gigli M, Pinamonti B, Sinagra G, Dores E, Matera A, Innelli P, Innelli P, Lopizzo A, Violini R, Fiorilli R, Cappabianca G, Picano E, Tarsia G, Seo J, Chang HJ, Heo R, Kim IC, Shim CY, Hong GR, Chung N, Melissopoulou MM, Nguyen V, Brochet E, Cimadevilla C, Codogno I, Vahanian A, Messika-Zeitoun D, Pontana F, Vassiliou V, Prasad S, Leclercq C, Samset E, Donal E, Lim DS, Bianchi G, Rossi F, Gianetti J, Marchi F, Cerone E, Nardelli A, Terrazzi M, Solinas M, Maffei S, Pshepiy A, Vasina L, Timofeev E, Reeva S, Zemtsovsky E, Brugger N, Jahren S, De Marchi SF, Seiler C, Jin CN, Tang H, Fan K, Kam K, Yan BP, Yu CM, Lee PW, Reali M, Silvetti E, Salatino T, Mancone M, Pennacchi M, Giordano A, Sardella G, Agati L, Tirado G, Nogales-Romo MT, Marcos-Alberca P, De Agustin A, Almeria C, Rodrigo JL, Garcia Fernandez MA, Macaya C, Perez De Isla L, Mancisidor M, Lara Garcia C, Vivancos R, De Mora M, Petrovic M, Vujisic-Tesic B, Trifunovic D, Boricic-Kostic M, Petrovic I, Draganic G, Petrovic O, Tomic-Dragovic M, Furlan T, Ambrozic J, Mohorko Pleskovic PN, Bunc M, Ribeiras R, Abecasis J, Andrade MJ, Mendes M, Ramakrishnan S, Gupta SK, Juneja R, Kothari SS, Zaleska M, Segiet A, Chwesiuk S, Kroc A, Kosior DA, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Rota C, Guaricci AI, Pepi M, Pons Llinares J, Asmarats Serra L, Pericas Ramis P, Caldes Llull O, Grau Sepulveda A, Frontera G, Vaquer Segui A, Noris M, Bethencourt Gonzalez A, Climent Paya V, Martinez Moreno M, Saura D, Oliva MJ, Sanchez Quinones J, Garcia Honrubia A, Valdes M, De La Morena G, Terricabras M, Costabel JP, Ronderos R, Evangelista A, Venturini C, Galve E, Nemes A, Neubauer S, Rahman Haley S, Banner N, Teixeira R, Caetano F, Almeida I, Trigo J, Botelho A, Silva J, Nascimento J, Goncalves L, Tesic M, Jovanovic I, Petrovic O, Boricic-Kostic M, Dragovic M, Petrovic M, Stepanovic J, Banovic M, Vujisic-Tesic B, Guergelcheva V, Chamova T, Sarafov S, Tournev I, Denchev S, Ikonomidis I, Psarogiannakopoulos P, Tsirigotis P, Paraskevaidis I, Lekakis J, Pelliccia A, Natali BM, Cameli M, Focardi M, Bonifazi M, Mondillo S, Lima C, Assed L, Kalil Filho R, Mady C, Bochi EA, Salemi VMC, Targher G, Valbusa F, Rossi A, Lanzoni L, Lipari P, Zenari L, Molon G, Canali G, Barbieri E, Li L, Craft M, Nanda M, Lorenzo JM, Kutty S, Bombardini T, Sparla S, Di Tommaso C, Losito M, Incampo E, Maccherini M, Mondillo S, Werther Evaldsson A, Radegran G, Stagmo M, Waktare J, Roijer A, Meurling CJ, Hui W, Meijboom FJ, Bijnens B, Dragulescu A, Mertens L, Friedberg MK, Sensoy B, Suleymanoglu M, Akin Y, Sahan E, Sasmaz H, Pasca L, Buzdugan E, Chis B, Stoicescu L, Lynce FC, Smith KL, Mete M, Isaacs C, Viapiana O, Di Nora C, Ognibeni F, Fracassi E, Giollo A, Mazzone C, Faganello G, Di Lenarda A, Rossini M, Galrinho A, Branco L, Timoteo AT, Rodrigues I, Daniel P, Rosa S, Ferreira L, Ferreira R, Polak L, Krauza G, Stokfisz K, Zielinska M, Branco LM, Galrinho A, Mota Carmo M, Teresa Timoteo A, Aguiar Rosa S, Abreu J, Pinto Teixeira P, Viveiros Monteiro A, Cruz Ferreira R, Peeraphatdit T, Chaiteerakij R, Klarich KW, Masia S, Necas J, Nistri S, Negri F, Barbati G, Cioffi G, Russo G, Mazzone C, Faganello G, Pandullo C, Di Lenarda A, Durante A, Rovelli E, Genchi V, Trabattoni L, Zerboni SC, Cattaneo L, Butti E, Ferrari G, Luneva E, Mitrofanova L, Uspensky V, Zemtsovsky E, Kasprzak JD, Rosner S, Karl M, Ott I, Sonne C, Ali Lahmar HM, Hammou L, Forsey J, Gowing L, Miller F, Ramanujam P, Stuart AG, Williams CA, Bandera F, Pellegrino M, Carbone F, Labate V, Alfonzetti E, Guazzi M, Patel NR, Raju P, Beale L, Brickley G, Lloyd GW, Fernandez-Golfin C, Gonzalez A, Rincon LM, Hinojar R, Garcia A, Megias A, Jimenez-Nacher JJ, Moya JL, Zamorano JL, Molon G, Canali G, Bonapace S, Chiampan A, Albrigi L, Barbieri E, Noris Mora M, Rodriguez Fernandez A, Exposito Pineda C, Grande C, Gonzalez Colino R, Macaya Ten F, Fernandez Vazquez X, Fortuny Frau E, Bethencourt Gonzalez A, Karvandi M, Blaszczyk R, Zarczuk R, Brzozowski W, Janowski M, Wysokinski A, Stanczyk B, Myftiu S, Teferici D, Quka A, Dado E, Djamandi J, Kresto L, Duka A, Kristo A, Balla I, Issa Z, Moiduddin N, Siblini G, Bulbul Z, Abid L, Abid D, Kammoun S, Rush E, Craft M, Goodwin J, Kreikemeier R, Cantinotti M, Kutty S, Zolaly MA, Khoshhal SQ, El-Harbi K, Tarawah A, Al-Hawsawi Z, Al-Mozainy I, Bakhoum SWG, Nabil MN, Elebrashy IN, Chinali M, Albanese S, Carotti A, Iacobelli R, Esposito C, Secinaro A, Moscogiuri G, Pasquini L, Malvezzi Caracciolo M, Bianchi RM, Caso P, Arenga F, Riegler L, Scarafile R, D'andrea A, Russo MG, Calabro' P, Simic DS, Peric VP, Mujovic NM, Marinkovic MM, Jankovic NJ, Shim A, Wejner-Mik P, Kasprzak JD, Lipiec P, Jain N, Kharwar R, Saran RK, Narain VS, Dwivedi SK, Sethi R, Chandra S, Pradhan A, Safal S, Marchetti MF, Cacace C, Congia M, Nissardi V, Ruscazio M, Meloni L, Montisci R, Gallego Sanchez G, Calero S, Portero JJ, Tercero A, Garcia JC, Barambio M, Martinez Lazaro R, Meretta AH, Perea GO, Belcastro F, Aguirre E, De Luca I, Henquin R, Masoli O. Poster session 2THE IMAGING EXAMINATIONP536Appropriate use criteria of transthoracic echocardiography and its clinical impact: a continuous challengeP537Implementation of proprietary plug-ins in the DICOM-based computerized echo reporting system fuels the use of 3D echo and deformation imaging in the clinical routine of a multivendor laboratoryP538Exercise stress echocardiography appropriate use criteria: real-life cases classification ease and agreement among cardiologistsANATOMY AND PHYSIOLOGY OF THE HEART AND GREAT VESSELSP539Functional capacity in older people with normal ejection fraction correlates with left ventricular functional reserve and carotid-femoral pulse wave velocity but not with E/e and augmentation indexP540Survey of competency of practitioners for diagnosis of acute cardiopulmonary diseases manifest on chest x-rayASSESSMENT OF DIAMETERS, VOLUMES AND MASSP541Left atrium remodeling in dialysis patients with normal ejection fractionP542The prediction of postinfarction left ventricular remodeling and the role of of leptin and MCP-1 in regard to the presence of metabolic syndromeP543Ascending aorta and common carotid artery: diameters and stiffness in a group of 584 healthy subjectsAssessments of haemodynamicsP544Alternate echo parameters in patients without estimable RVSPAssessment of systolic functionP545Reduced contractile performance in heart failure with preserved ejection fraction: determination using novel preload-adjusted maximal left ventricular ejection forceP546Left ventricular dimensions and prognosis in acute coronary syndromesP547Time course of myocardial alterations in a murine model of high fat diet: A strain rate imaging studyP548Subclinical left ventricular systolic dysfunction in patients with premature ventricular contractionsP549Global myocardial strain by CMR-based feature tracking (FT) and tagging to predict development of severe left ventricular systolic dysfunction after acute st-elevation myocardial infarctionP550Echocardiographic analysis of left and right ventricular function in patients after mitral valve reconstructionP551The role of regional longitudinal strain assessment in predicting response to cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and left bundle branch blockP552Speckle tracking automatic border detection improves echocardiographic evaluation of right ventricular systolic function in repaired tetralogy of fallot patients: comparison with MRI findingsP553Echocardiography: a reproducible and relevant tool in pah? intermediate results of the multicentric efort echogardiographic substudy (evaluation of prognostic factors and therapeutic targets in pah)Assessment of diastolic functionP554Relationship between left ventricular filling pressures and myocardial fibrosis in patients with uncomplicated arterial hypertensionP555Cardiac rehabilitation improves echocardiographic parameters of diastolic function in patients with ischemic heart diseaseP556Diastolic parameters in the calcified mitral annulusP557Biomarkers and echocardiography - combined weapon to diagnose and prognose heart failure with and without preserved ejection fractionP558Diastolic function changes of the maternal heart in twin and singleton pregnancyIschemic heart diseaseP559Syntax score as predictor for the correlation between epicardial adipose tissue and the severity of coronary lesions in patients with significant coronary diseaseP560Impact of strain analysis in ergonovine stress echocardiography for diagnosis vasospastic anginaP561Cardiac magnetic resonance tissue tracking: a novel method to predict infarct transmurality in acute myocardial infarctionP562Infarct size is correlated to global longitudinal strain but not left ventricular ejection fraction in the early stage of acute myocardial infarctionP563Magnetic resonance myocardial deformation assessment with tissue tracking and risk stratification in acute myocardial infarction patientsP564Increase in regional end-diastolic wall thickness by transthoracic echocardiography as a biomarker of successful reperfusion in anterior ST elevation acute myocardial infarctionP565Mitral regurgitation is associated with worse long-term prognosis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionP566Statistical significance of 3D motion and deformation indexes for the analysis of LAD infarctionHeart valve DiseasesP567Paradoxical low gradient aortic stenosis: echocardiographic progression from moderate to severe diseaseP568The beneficial effects of TAVI in mitral insufficiencyP569Impact of thoracic aortic calcification on the left ventricular hypertrophy and its regression after aortic valve replacement in patients with severe aortic stenosisP570Additional value of exercise-stress echocardiography in asymptomatic patients with aortic valve stenosisP571Valvulo-arterial impedance in severe aortic stenosis: a dual imaging modalities studyP572Left ventricular mechanics: novel tools to evaluate left ventricular performance in patients with aortic stenosisP573Comparison of long-term outcome after percutaneous mitral valvuloplasty versus mitral valve replacement in moderate to severe mitral stenosis with left ventricular dysfunctionP574Incidence of de novo left ventricular dysfunction in patient treated with aortic valve replacement for severe aortic regurgitationP575Transforming growth factor-beta dependant progression of the mitral valve prolapseP576Quantification of mitral regurgitation with multiple jets: in vitro validation of three-dimensional PISA techniqueP577Impaired pre-systolic contraction and saddle-shape deepening of mitral annulus contributes to atrial functional regurgitation: a three-dimensional echocardiographic studyP578Incidence and determinants of left ventricular (lv) reverse remodeling after MitraClip implantation in patients with moderate-to severe or severe mitral regurgitation and reduced lv ejection fractionP579Severe functional tricuspid regurgitation in rheumatic heart valve disease. New insights from 3D transthoracic echocardiographyP58015 years of evolution of the etiologic profile for prosthetic heart valve replacement through an echocardiography laboratoryP581The role of echocardiography in the differential diagnosis of prolonged fever of unknown originP582Predictive value for paravalvular regurgitation of 3-dimensional anatomic aortic annulus shape assessed by multidetector computed tomography post-transcatheter aortic valve replacementP583The significance and advantages of echo and CT imaging & measurement at transcatherter aortic valve implantation through the left common carotid accessP584Comparison of the self-expandable Medtronic CoreValve versus the balloon-expandable Edwards SAPIEN bioprostheses in high-risk patients undergoing transfemoral aortic valve implantationP585The impact of transcatheter aortic valve implantation on mitral regurgitation severityP586Echocardiographic follow up of children with valvular lesions secondary to rheumatic heart disease: Data from a prospective registryP587Valvular heart disease and different circadian blood pressure profilesCardiomyopathiesP588Comparison of transthoracic echocardiography versus cardiac magnetic for implantable cardioverter defibrillator therapy in primary prevention strategy dilated cardiomyopathy patientsP589Incidence and prognostic significance of left ventricle reverse remodeling in a cohort of patients with idiopathic dilated cardiomyopathyP590Early evaluation of diastolic function in fabry diseaseP591Echocardiographic predictors of atrial fibrillation development in hypertrophic cardiomyopathyP592Altered Torsion mechanics in patients with hypertrophic cardiomyopathy: LVOT-obstruction is the topdog?P593Prevention of sudden cardiac death in hypertrophic cardiomyopathy: what has changed in the guidelines?P594Coronary microcirculatory function as determinator of longitudinal systolic left ventricular function in hypertrophic cardiomyopathyP595Detection of subclinical myocardial dysfunction by tissue Doppler ehocardiography in patients with muscular dystrophiesP596Speckle tracking myocardial deformation analysis and three dimensional echocardiography for early detection of chemotherapy induced cardiac dysfunction in bone marrow transplantation patientsP597Left ventricular non compaction or hypertrabeculation: distinguishing between physiology and pathology in top-level athletesP598Role of multi modality imaging in familiar screening of Danon diseaseP599Early impairment of global longitudinal left ventricular systolic function independently predicts incident atrial fibrillation in type 2 diabetes mellitusP600Fetal cardiovascular programming in maternal diabetes mellitus and obesity: insights from deformation imagingP601Longitudinal strain stress echo evaluation of aged marginal donor hearts: feasibility in the Adonhers project.P602Echocardiographic evaluation of left ventricular size and function following heart transplantation - Gender mattersSystemic diseases and other conditionsP603The impact of septal kinetics on adverse ventricular-ventricular interactions in pulmonary stenosis and pulmonary arterial hypertensionP604Improvement in right ventricular mechanics after inhalation of iloprost in pulmonary hypertensionP605Does the treatment of patients with metabolic syndrome correct the right ventricular diastolic dysfunction?P606Predictors of altered cardiac function in breast cancer survivors who were treated with anthracycline-based therapyP607Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis: a prospective tissue-doppler echocardiography studyP608Diastolic and systolic left ventricle dysfunction presenting different prognostic implications in cardiac amyloidosisP609Diagnostic accuracy of Bedside Lung Ultrasonography in Emergency (BLUE) protocol for the diagnosis of pulmonary embolismP610Right ventricular systolic dysfunction and its incidence in breast cancer patients submitted to anthracycline therapyP611Right ventricular dysfunction is an independent predictor of survival among cirrhotic patients undergoing liver transplantCongenital heart diseaseP612Hypoplasia or absence of posterior leaflet: a rare congenital anomaly of the mitral valveP613ECHO screening for Barlow disease in proband's relativesDiseases of the aortaP614Aortic size distribution and prognosis in an unselected population of patients referred for standard transthoracic echocardiographyP615Abdominal aorta aneurysm ultrasonographic screening in a large cohort of asympromatic volounteers in an Italian urban settingP616Thoracic aortic aneurysm and left ventricular systolic functionStress echocardiographyP617Wall motion score index, systolic mitral annulus velocity and left ventricular mass predicted global longitudinal systolic strain in 238 patients examined by stress echocardiographyP618Prognostic parameters of exercise-induced severe mitral valve regurgitation and exercise-induced systolic pulmonary hypertensionP619Risk stratification after myocardial infarction: prognostic value of dobutamine stress echocardiographyP620relationship between LV and RV myocardial contractile reserve and metabolic parameters during incremental exercise and recovery in healthy children using 2-D strain analysisP621Increased peripheral extraction as a mechanism compensatory to reduced cardiac output in high risk heart failure patients with group 2 pulmonary hypertension and exercise oscillatory ventilationP622Can exercise induced changes in cardiac synchrony predict response to CRT?Transesophageal echocardiographyP623Fully-automated software for mitral valve assessment in chronic mitral regurgitation by three-dimensional transesophageal echocardiographyP624Real-time 3D transesophageal echocardiography provides more accurate orifice measurement in percutaneous transcatheter left atrial appendage closureP625Percutaneous closure of left atrial appendage: experience of 36 casesReal-time three-dimensional TEEP626Real-time three-dimensional transesophageal echocardiography during pulmonary vein cryoballoon ablation for atrial fibrilationP627Three dimensional ultrasound anatomy of intact mitral valve and in the case of type 2 disfunctionTissue Doppler and speckle trackingP629Left ventricle wall motion tracking from echocardiographic images by a non-rigid image registrationP630The first experience with the new prototype of a robotic system for remote echocardiographyP631Non-invasive PCWP influence on a loop diuretics regimen monitoring model in ADHF patients.P632Normal range of left ventricular strain, dimensions and ejection fraction using three-dimensional speckle-tracking echocardiography in neonatesP633Circumferential ascending aortic strain: new parameter in the assessment of arterial stiffness in systemic hypertensionP634Aortic vascular properties in pediatric osteogenesis imperfecta: a two-dimensional echocardiography derived aortic strain studyP635Assessment of cardiac functions in children with sickle cell anemia: doppler tissue imaging studyP636Assessment of left ventricular function in type 1 diabetes mellitus patients by two-dimensional speckle tracking echocardiography: relation to duration and control of diabetesP637A study of left ventricular torsion in l-loop ventricles using speckle-tracking echocardiographyP638Despite No-Reflow, global and regional longitudinal strains assessed by two-dimensional speckle tracking echocardiography are predictive indexes of left ventricular remodeling in patients with STEMIP639The function of reservoir of the left atrium in patients with medicaly treated arterial hypertensionP640The usefulness of speckle tracking analysis for predicting the recovery of regional systolic function after myocardial infarctionP641Two dimensional speckle tracking echocardiography in assessment of left ventricular systolic function in patients with rheumatic severe mitral regurgitation and normal ejection fractionP642The prediction of left-main and tripple vessel coronary artery disease by tissue doppler based longitudinal strain and strain rate imagingP643Role of speckle tracking in predicting arrhythmic risk and occurrence of appropriate implantable defibrillator Intervention in patients with ischemic and non-ischemic cardiomyopathyComputed Tomography & Nuclear CardiologyP644Cardiac adrenergic activity in patients with nonischemic dilated cardiomyopathy. Correlation with echocardiographyP645Different vascular territories and myocardial ischemia, there is a gradient of association? Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
13
|
Alés-Martínez JE, Ruiz A, Chacón JI, Lluch Hernández A, Ramos M, Córdoba O, Aguirre E, Barnadas A, Jara C, González S, Plazaola A, Florián J, Andrés R, Sánchez Rovira P, Frau A. Preventive treatments for breast cancer: recent developments. Clin Transl Oncol 2014; 17:257-63. [PMID: 25445174 PMCID: PMC4357652 DOI: 10.1007/s12094-014-1250-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2014] [Accepted: 10/17/2014] [Indexed: 11/15/2022]
Abstract
Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.
Collapse
Affiliation(s)
- J E Alés-Martínez
- Hospital Nuestra Señora de Sonsoles, GEICAM Spanish Breast Cancer Group, Ávila, Spain,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Aguirre E, Renner O, de Miguel MR, Albarran M, Cebria A, Cebrian D, Ramos-Lima F, Pastor J, Blanco-Aparicio C. 198 Genetic and pharmacological inhibition of PIM-1 reduces tumor development in a K-Ras-driven mouse model of non-small cell lung cancer. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70324-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Andrés R, Pajares I, Balmaña J, Llort G, Ramón y Cajal T, Chirivella I, Aguirre E, Robles L, Lastra E, Pérez-Segura P, Bosch N, Yagüe C, Lerma E, Godino J, Miramar MD, Moros M, Astier P, Saez B, Vidal MJ, Arcusa A, Ramón y Cajal S, Calvo MT, Tres A. Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). Clin Transl Oncol 2013; 16:280-4. [DOI: 10.1007/s12094-013-1070-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2013] [Accepted: 06/16/2013] [Indexed: 11/24/2022]
|
16
|
Opazo A, Aguirre E, Saldaña E, Fantova MJ, Clavé P. Patterns of impaired internal anal sphincter activity in patients with anal fissure. Colorectal Dis 2013; 15:492-9. [PMID: 23216966 DOI: 10.1111/codi.12095] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/04/2012] [Accepted: 08/14/2012] [Indexed: 01/22/2023]
Abstract
AIM The patterns of impaired internal anal sphincter activity were studied in patients with anal fissure (AF). METHOD Twenty healthy controls and 61 patients with acute AF were studied, using anorectal manometry with electromyography (EMG), and 53 patients with chronic AF using high-resolution manometry and ultrasonography. Mean and maximal resting anal pressure (MRAP), spontaneous rhythmic slow and ultraslow waves (USW) and relaxation induced by rectal distension were measured. RESULTS Patients with acute AF had higher mean (106.4 ± 28.1 mmHg) and maximal resting anal pressure (161.5 ± 43.7 mmHg) than those with chronic AF (P < 0.05); 95% of patients had slow waves (SW) and 67% ultraslow waves. Patients with chronic AF had higher mean (92.4 ± 22.6 mmHg) and maximal resting anal pressure (117.5 ± 32.0 mmHg) than controls and 94% of patients had slow waves and 69% ultraslow waves. Patients with ultraslow waves (with either acute or chronic AF) had increased internal sphincter hypertonicity (mean and maximal resting pressure), decreased internal sphincter relaxation and increased after-contraction following rectal distension. CONCLUSIONS Patients with acute AF had higher hypertonicity than those with chronic AF and both had increased spontaneous rhythmic activity (waves). Patients with AF and ultraslow waves had higher internal anal sphincter hypertonicity and reduced internal sphincter relaxation and enhanced after-contraction following rectal distension.
Collapse
Affiliation(s)
- A Opazo
- Department of Surgery, Hospital de Mataró, Barcelona, Spain
| | | | | | | | | |
Collapse
|
17
|
Aguirre E, Hoare Z, Streater A, Spector A, Woods B, Hoe J, Orrell M. Cognitive stimulation therapy (CST) for people with dementia--who benefits most? Int J Geriatr Psychiatry 2013; 28:284-90. [PMID: 22573599 DOI: 10.1002/gps.3823] [Citation(s) in RCA: 78] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2011] [Accepted: 04/11/2012] [Indexed: 11/06/2022]
Abstract
BACKGROUND The efficacy of cognitive stimulation therapy (CST) has been demonstrated, but little is known about the characteristics of people with dementia, which may predict a more positive response to CST. This study sought to investigate which factors may predict response to CST. METHODS Two hundred and seventy-two participants with dementia took part in a 7-week CST intervention. Assessments were carried out pre-treatment and post-treatment. The results were compared with those of a previous comparable CST randomised control trial. A comparison of mean scores pre-CST and post-CST groups was undertaken, and contributing factors that predicted change in outcomes were examined. RESULTS CST improved cognition and quality of life, and the results showed that the benefits of CST were independent of whether people were taking acetylcholinesteraseinhibitor (AChEI) medication. Increasing age was associated with cognitive benefits, as was female gender. Care home residents improved more than community residents on quality of life, but the community sample seemed to benefit more in relation to behaviour problems. CONCLUSIONS These results demonstrate that CST improves cognition and quality of life for people with dementia including those already on AChEIs. Older age and being female were associated with increased cognitive benefits from the intervention. Consideration should be given to aspects of CST, which may enhance the benefits for people with dementia who are male and those younger than 80 years.
Collapse
Affiliation(s)
- E Aguirre
- Mental Health Sciences Department, University College London, Charles Bell House, 67-73 Riding House Street, London, UK.
| | | | | | | | | | | | | |
Collapse
|
18
|
Morales S, Samame J, Taberner T, Aguirre E, Llombart A. Clinical efficacy of Bevacizumab plus Taxane in Metastatic Breast Cancer in a single institution. Breast 2011. [DOI: 10.1016/j.breast.2011.08.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
19
|
Rosas A, Aguirre E, Arsuaga JL, Bermúdez de Castro JM, Martínez I. Los fósiles humanos de Ibeas (Sierra de Atapuerca, Burgos). Inventario y determinación del número mínimo de individuos. ACTA ACUST UNITED AC 2010. [DOI: 10.3989/egeol.86426782] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
20
|
Perez A, Sierra B, Garcia G, Aguirre E, Alvarez M, Sanchez L, Volk H, Guzman M. Role of IL-10 in Dengue Infection: Pathogenic or Protective? Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
21
|
Sierra B, Perez A, Vogt K, García G, Schmolke K, Aguirre E, Alvarez M, Kouri G, Volk H, Guzman M. Role of the Cytokines and Chemokines in the Regulation of Innate Immunity in Dengue Virus Infection. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
22
|
Perez A, Sierra B, Garcia G, Alegre R, Aguirre E, Sanchez L, Alvarez M, Volk H, Kanki P, Guzmán M. Host Gene Polymorphism and Dengue Disease Susceptibility. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
23
|
García G, Pérez A, Sierra B, Aguirre E, Izquierdo A, Sanchez L, Rosado I, Borroto S, Hirayama K, Guzmán M. IgG Subclass and the FcG Receptor Iia Polymorphism Associate to Dengue Fever, Dengue Hemorrhagic Fever and Asymptomatic Dengue Infection in Cuba. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
24
|
Sierra B, Perez A, García G, Vogt K, Schmolke K, Aguirre E, Kern F, Alvarez M, Volk H, Guzman M. Racial Variation in the Cytokines Production During Dengue Infection. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
25
|
López-Velázquez L, Aguirre E, Paredes RG. Kindling increases aversion to saccharin in taste aversion learning. Neuroscience 2007; 144:808-14. [PMID: 17140739 DOI: 10.1016/j.neuroscience.2006.09.063] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2006] [Revised: 09/20/2006] [Accepted: 09/29/2006] [Indexed: 11/27/2022]
Abstract
Kindling is a model in which an initially subconvulsive electrical stimulation of certain brain areas eventually develops a generalized seizure that produces behavioral and long term neuronal changes. In the present study we evaluated if kindling can modify conditioning taste aversion (CTA). In this paradigm animals acquire aversion to saccharin when it is presented as the conditioned stimulus (CS) followed by an injection of lithium chloride (LiCl) that induces a gastric irritation as the unconditioned stimulus (US). Male Wistar rats were implanted with bipolar electrodes aimed at the right amygdala (AMG) or at the right insular cortex (IC). The animals were stimulated daily until they reached stages 2-4 (intermediate) or until kindling was fully established (three consecutive stage 5 seizures). At least two weeks after kindling stimulation had ceased the animals were deprived of water for 24 h and given 10-min drinking sessions twice a day for 4 days. On day 5 (morning session) tap water was replaced by saccharin solution (0.1%), 20 min later the animals were injected with LiCl (7.5 ml/kg i.p., 0.2 M) to induce gastric malaise or taste aversion. After three more days of baseline consumption, water was substituted by a fresh 0.1% saccharin solution to test the aversion. AMG-kindling delayed the extinction of CTA. Animals with kindling in the IC had a higher retention than the sham kindling group; that is, they drank significantly less saccharin solution than the other groups. The results of the present experiment show that local modification of brain function induced by kindling stimulation can prolong the aversive effects of CTA.
Collapse
Affiliation(s)
- L López-Velázquez
- Instituto de Neurobiología, Universidad Nacional Autónoma de México, Apartado Postal 1-1141, Querétaro, Qro. C.P. 76001, Mexico
| | | | | |
Collapse
|
26
|
Solano‐Agama C, González‐Nava B, Azorín E, Réyes‐Márquez B, Pliego MG, Aguirre E, Mendoza‐Garrido ME. [P96]: Association and organization of cultured rat infantile pituitary cells after cell migration. Int J Dev Neurosci 2006. [DOI: 10.1016/j.ijdevneu.2006.09.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Affiliation(s)
- C. Solano‐Agama
- Department of Physiology, Biophysics and NeuroscienceCINVESTAVMexico
| | - B. González‐Nava
- Department of Physiology, Biophysics and NeuroscienceCINVESTAVMexico
| | - E. Azorín
- Department of Physiology, Biophysics and NeuroscienceCINVESTAVMexico
| | | | | | - E. Aguirre
- Department of Embryology, Medicine FacultyUNAMMexico
| | | |
Collapse
|
27
|
García G, Arango M, Pérez AB, Fonte L, Sierra B, Rodríguez-Roche R, Aguirre E, Fiterre I, Guzmán MG. Antibodies from patients with dengue viral infection mediate cellular cytotoxicity. J Clin Virol 2006; 37:53-7. [PMID: 16787760 DOI: 10.1016/j.jcv.2006.04.010] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2006] [Accepted: 04/24/2006] [Indexed: 11/25/2022]
Abstract
Acute and late convalescent sera (collected at day 5 of disease onset and 1 year later) from dengue fever (DF) and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) laboratory confirmed cases, were tested for antibody-dependent cell-mediated cytotoxicity (ADCC) activity using dengue 1 (DENV-1) or dengue 2 (DENV-2) infected cells as target. All patients experienced their first dengue virus (DENV) infection 20 years before. ADCC activity was detected in acute sera from DHF/DSS but not in sera from DF patients. However, 1 year after illness, ADCC activity was observed in all cases. This preliminary report represents one of the few studies of ADCC in dengue patients and suggests that ADCC could be implicated in dengue pathogenesis.
Collapse
Affiliation(s)
- G García
- Department of Virology, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Tropical Medicine Institute, Autopista Novia del Mediodía, Km 6. P.O. Box Marianao 13, Havana, Cuba
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Ortega M, Ruiz-Echarri M, Prats E, Lastra R, Aguirre E, Lambea J, Milastre E, Mayordomo J, Razola P, Tres A, Banzo J. What is the yield of regional lymph node dissection following sentinel lymph node involvement in patients with breast cancer? J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.10782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10782 Background: Sentinel lymph node is a minimally invasive and accurate staging procedure for patients with invasive breast cancer. Histological SLN involvement with cancer cells requires regional lymph node dissection. Aim: To verify if subgroups of patients with sentinel lymph node involvement in which the risk of histological involvement of additional regional lymph nodes is minimal can be identified. Methods: Ninety six consecutive patients with invasive breast cancer and tumour size less than two centimeters by mammography, had lymphoscintigraphy with colloidal 99Tc and radioisotope-guided sentinel lymph node biopsy in the University Hospital of Zaragoza from 1999 to 2005.Pathological assessment included serial sections of the sentinel lymph node with inmunohistochemistry for cytokeratins in selected cases.39 patients had histological involvement and are presented in this analysis. Results: All 39 patients were females. Median tumour size was 20 mm (range 5–52) Median number of resected sentinel lymph node was 2 (range 1–5) Median number of involved sentinel lymph node was 1 (range 1–4) Regional lymph node dissection was performed in all patients (Axillary dissection in 31; internal mammary dissection in 1, both in 7). Median number of nodes was 13 (range 2–34) At least 1 additional involved lymph node was found in 19 patients (48%) We have correlated patient age, menopausal status, pathological tumour size, histological grade, estrogen receptors, progesterone receptors and Her2 with the risk of histological lymph node involvement in regional lymph node dissection. Conclusions: Tumour size was significantly associated to such risk: No significant financial relationships to disclose.
Collapse
Affiliation(s)
- M. Ortega
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | | | - E. Prats
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | - R. Lastra
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | - E. Aguirre
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | - J. Lambea
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | - E. Milastre
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | | | - P. Razola
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | - A. Tres
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| | - J. Banzo
- Hospital Clinico Lozano Blesa, Zaragoza, Spain
| |
Collapse
|
29
|
Millastre E, Ruiz-Echarri Sr. M, Ortega M, Mayordomo JI, Lastra R, Prats E, Lambea J, Aguirre E, Razola P, Andrés R, Tres A, Banzo J. Axillary lymphadenectomy can be safely avoided in patients with breast cancer and negative sentinel lymph node biopsy. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.10787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10787 Background: Patients with breast cancer in which sentinel lymph node biopsy is histologically negative for tumor cells, have a low probability of having involvement of additional regional lymph nodes. Lymph node dissection may be avoided in these cases. Methods: Ninety-six consecutive patients with invasive breast cancer and tumour size less than 2 centimeters by mammography, had lymphoscintigraphy with colloidal 99Tc and radioisotope-guided sentinel lymph node biopsy in the University Hospital of Zaragoza from 1999 to 2005.Pathological assessment included serial sections of the sentinel lymph node with immunohistochemistry for cytokeratins in selected cases. Results: Sentinel lymph node biopsy was negative in 57 patients. There were 56 females and 1 male. Median age was 57 years (range 24–87). Median pathological tumor size was 15 mm (range 5–31). Location of the sentinel lymph node was axillary in 47patients, internal mammary in 0 patients, and both in 10 patients. Median number of resected lymph nodes was 2 (range 1–4). With median follow-up of 33 months, no local or systemic relapses have occurred. Conclusions: Avoidance of regional lymph node dissection is safe in patients with breast cancer and histologically negative sentinel lymph node biopsy. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- E. Millastre
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | | | - M. Ortega
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | | | - R. Lastra
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - E. Prats
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - J. Lambea
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - E. Aguirre
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - P. Razola
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - R. Andrés
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - A. Tres
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| | - J. Banzo
- Hospital Clínico Universitario de Zaragoza, Zaragoza, Spain
| |
Collapse
|
30
|
Lambea JJ, Alvarez I, Lastra R, Ortega M, Aguirre E, Ruiz-Echarri M, Millastre E, Mayordomo JI, Escudero P, Storkus W, Tres A. Promising targets in renal cell cancer: Met and ron-beta. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.20119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
20119 Background: The activation of Tyrosin Kinase Receptors (RTKs) produces several effects about cellular response. These are membrane receptors that bind differentiation signals, grow factors and cellular mediators. The interaction with their ligand causes the phosphorilation and internalization in the endosome. By a metabolic way, these receptors are degradated into the proteasome to small peptides that are expressed over the cellular surface joined to MHC class I mollecules, getting a better immunogenic recognition of the tumor cells. It is known that the bigger expression of the tyrosin kinase receptors in tumors is associated with an aggressive phenotype. For example overexpression of ephA2 or EGFR. Our study is based in the demostration of the overexpression of other receptors in renal cell cancer, a tumour with a disappointing response with treatment in advanced stages. On this way we can use them as targets for monoclonal antibodies and for citotoxic lymphocites CD8 stimulated that will join to peptides presented in MHC class I after the proteasomic degradation. Methods: We use Western-Blot for identifying the overexpressed RTKs in relation to normal tissue and as a reference the expression of beta-actin, that is present in every cells. The cells are from 5 murine renal cell cancer lines, (thanks to Hillman Cancer Center Institute, University of Pittsburgh. Pennsylvania. USA). The control is a murine cell line that is very similar to normal renal tissue (HK). We calculate the ratio of expression compared with the expression of normal tissue with an statistical analysis. Results: HER-2, VEGFR-2, Met, Ron-beta are overexpresed in renal cell cancer in a murine model, as EGFR (epidermic growing factor receptor). Conclusions: Met may be excellent therapeutic and inmunologic target and in selected cases of renal cell cancer. It’s known that EGFR and VEGFR are also good targets. Future research about these targets will get new options of combined immunotherapy (vaccines and monoclonal antibodies). No significant financial relationships to disclose.
Collapse
Affiliation(s)
- J. J. Lambea
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - I. Alvarez
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - R. Lastra
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - M. Ortega
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - E. Aguirre
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - M. Ruiz-Echarri
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - E. Millastre
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - J. I. Mayordomo
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - P. Escudero
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - W. Storkus
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| | - A. Tres
- Hospital Clinico Lozano Blesa, Zaragoza, Spain; University of Pittsburgh, Pittsburgh, PA
| |
Collapse
|
31
|
Abstract
This paper reports the first genetic characterization of Anaplasma (Ehrlichia) platys in Spain from a naturally infected dog. The dog presented clinical signs compatible with canine ehrlichiosis. After DNA extraction and PCR amplification, 16S rRNA gene and citrate synthase gene ( gltA) of this agent were amplified. The GenBank accession number for the nucleotide sequence of the 16S rRNA gene of this strain is AY530806. The A. platys strains registered in France and Japan showed the highest similarity to the 16S rRNA gene sequence obtained from the Spanish strain. In the amplification of the gltA gene, a 1443 bp fragment was obtained, and three nucleotide differences were detected in comparison with other strains sequences. These data confirm the presence of A. platys in a dog showing clinical signs compatible with ehrlichiosis in Spain.
Collapse
Affiliation(s)
- E Aguirre
- Departamento de Medicina y Cirugía Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | | | | | | | | |
Collapse
|
32
|
Abstract
AIM To evaluate the energy requirements of breast fed infants. METHODS The study was conducted in 17 healthy exclusively breast fed infants of normal birth weight (mean (SD) 3332 (280) g). Energy expenditure by the doubly labelled water method and milk intake by the dose to infant method were measured at 34 (4) days. A dose of 0. 2 g/kg deuterium oxide (99.8%) and 2.0 g/kg 10% (18)O labelled water was given to the infants, and urine samples were collected for seven consecutive days after dosing. RESULTS The mean (SD) weight of the infants during the period of evaluation was 4617 (343) g and weight gain 34.0 (7.5) g/day. Daily milk intake was 728 (101) g and its metabolisable energy content 2.71 kJ/g. The energy expenditure of the infants was 1205 (312) kJ/day and energy required for growth was 607 (130) kJ/day. When combined this produced an energy requirement of 391 kJ/kg/day for these infants. CONCLUSION These data agree with those from other studies in the United Kingdom and the United States and suggest that adequate growth can be achieved with 19.4% less energy than recommended by FAO/WHO/UNU.
Collapse
Affiliation(s)
- G Salazar
- Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile.
| | | | | | | | | |
Collapse
|
33
|
Abstract
The postictal behavioral depression (PBD), characterized by behavioral immobility and unresponsiveness to environmental stimuli, observed after a stage 5 kindling seizure is opioid dependent. Morphine injection prolongs while naloxone and naltrexone (opioid antagonists) reduce or eliminate PBD. Opioids have clear rewarding actions that can be easily detected by place preference conditioning (PPC). In the present study, we evaluated if the opioid release after a stage 5 kindling seizure that produces PBD could induce PPC. Male rats were kindled in the medial preoptic area (MPOA), the amygdala (AMG) or insular cortex (IC). After kindling was established their initial preference in a three-compartment chamber was determined. During conditioning, subjects received a standard kindling stimuli that evoked a stage 5 seizure. At the end of the after discharge and during the PBD the animals were placed in the non-preferred chamber for 30 min. On alternate days they were placed without stimulation in the preferred chamber. At the end of conditioning the kindled groups showed a clear change of preference. This change of preference was completely blocked by injection of naloxone. These results suggest that opioid release after a stage 5 kindling seizure can induce a positive affect of sufficient intensity and duration to induce conditioning.
Collapse
Affiliation(s)
- R G Paredes
- Centro de Neurobiologia, Universidad Nacional Autónoma de México, Querétaro.
| | | | | | | |
Collapse
|
34
|
|
35
|
Delezé M, Cons-Molina F, Villa AR, Morales-Torres J, Gonzalez-Gonzalez JG, Calva JJ, Murillo A, Briceño A, Orozco J, Morales-Franco G, Peña-Rios H, Guerrero-Yeo G, Aguirre E, Elizondo J. Geographic differences in bone mineral density of Mexican women. Osteoporos Int 2000; 11:562-9. [PMID: 11069189 DOI: 10.1007/s001980070076] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The aim of this study was to generate standard curves for normal spinal and femoral neck bone mineral density (BMD) in Mexican women using dual-energy X-ray absorptiometry (DXA), to analyze geographic differences and to compare these with 'Hispanic' reference data to determine its applicability. This was a cross-sectional study of 4460 urban, clinically normal, Mexican women, aged 20-90 years, from 10 different cities in Mexico (5 in the north, 4 in the center and 1 in the southeast) with densitometry centers. Women with suspected medical conditions or who had used drugs affecting bone metabolism, were excluded. Lumbar spine BMD was significantly higher (1.089 +/- 0.18 g/cm2) in women from the northern part of Mexico, with intermediate values in the center (1.065 +/- 0.17 g/cm2) and lower values (1.013 +/- 0.19 g/cm2) in the southeast (p < 0.0001). Similarly, femoral neck BMD was significantly higher in women from the north (0.895 +/- 0.14 g/cm2), intermediate in the center (0.864 +/- 0.14 g/cm2) and lower (0.844 +/- 0.14 g/cm ) in the southeast part of Mexico (p < 0.0001). Northern Mexican women tend to be taller and heavier than women from the center and, even more, than those from the southeast of Mexico (p < 0.0001). However, these differences in BMD remained significant after adjustment for weight (p < 0.0001). A significant loss (p < 0.0001) in BMD was observed from 40 to 69 years of age at the lumbar spine and up to the eighth decade at the femoral neck. Higher and lower lumbar spine values, as compared with the 'Hispanic' population, were observed in Mexican mestizo women from the northern and southeastern regions, respectively. In conclusion, there are geographic differences in weight and height of Mexican women, and in BMD despite adjustment for weight.
Collapse
Affiliation(s)
- M Delezé
- Clínica de osteoporosis del Centro de Hematología y Medicina Intema de Puebla, PUE, Mexico.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Jorquera H, Acuña M, Cifuentes L, Aguirre E, Moreno F. [Paternity analysis using four DNA markers amplified by polymerase chain reaction]. Rev Med Chil 1999; 127:1057-62. [PMID: 10752268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
BACKGROUND DNA typing in forensic analysis is a useful tool to analyze paternity due to its high discrimination power. AIM To report the experience of Servicio Medico Legal in Santiago, resolving cases of dubious paternity. SUBJECTS AND METHODS Four highly polymorphic loci, amplified by polymerase chain reactions, were analyzed in 153 cases of uncertain paternity. The paternity index was calculated for each case. RESULTS The four genetic markers analyzed provided an exclusion probability of 0.933 for the general population in Santiago. Thirty-seven cases were excluded as parents. In 31 cases, the paternity index ranged from 19 to 100, considered as probable paternity and 77 cases had an index of over 100, considered as almost certain paternity. Eight cases had an index between 0.5 and 19, considered as inconclusive. All loci met Hardy-Weinberg expectations and their frequencies were similar to other data from people living in Santiago. CONCLUSIONS The use of these genetic markers proved to be very useful, reliable and with a high exclusion power for paternity analysis.
Collapse
Affiliation(s)
- H Jorquera
- Departamento de Laboratorios, ICBM, Facultad de Medicina, Universidad de Chile.
| | | | | | | | | |
Collapse
|
37
|
Jorquera H, Cifuentes L, Moreno F, Aguirre E. Paternity analysis when the putative father is missing: first case in Chile. J Forensic Sci 1999; 44:627-9. [PMID: 10408120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
Genetic marker analysis is a powerful tool for solving paternity-related problems when the putative father is missing. This report describes the first time this approach was employed in Chile to solve such a problem. In the case presented, the alleged father was missing as a result of the political detentions that took place in Chile during 1973. It was not possible to obtain any biological sample from him because he was missing. Thus, the case was resolved by means of genetic marker analysis of the alleged father's close relatives.
Collapse
Affiliation(s)
- H Jorquera
- Depto. de Laboratorios, Ministerio de Justicia, Santiago, Chile
| | | | | | | |
Collapse
|
38
|
Murrillo-Uribe A, Delezé-Hinojosa M, Aguirre E, Villa A, Calva J, Cons F, Briseño A, González G, Morales J, Peña H, Guerrero G, Orozco J, Morales G, Elizondo J. [Osteoporosis in Mexican postmenopausal women. Magnitude of the problem. Multicenter study]. Ginecol Obstet Mex 1999; 67:227-33. [PMID: 10363426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
Incidencia of osteoporosis induced fractures increases with age; risk increases exponentially as bone mass decreases. Women are prone to osteoporosis 2 to 3 times more than men, due to lower "peak" bone mass and the accelerated loss that occurs after the menopause. The prevalence of osteoporosis in with Caucasian postmenopausal women varies from 16 to 30% depending upon the number of sites measured (lumbar spine/hip and/or forearm). The aim of this study was to estimate the prevalence of osteopenia and osteoporosis in pre and postmenopausal Mexican women in relation to men, and to that reported in Caucasia women. The study involved 4,821 apparently healthy subjects (without known risk factors for osteoporosis), 4,467 females and 354 males from 11 different centers of Mexican Republic, 20 to 90 years old, using DXA bone densitometry of lumbar spine and hip. Prevalence of osteoporosis in women is twice that in men (P < 0.001), and it increases with age, particularly after the menopause (P < 0.0001). Our study found a prevalence of osteoporosis of the lumbar spine and/or hip in apparently healthy postmenopausal Mexican women over 50 years of age of 16%, increasing to 20% in those women with or without risk factors who attended voluntarily or by suggestion of their physician to be studied. The prevalence values obtained seem to be lower than those reported for Caucasian women, 30%. We found a prevalence of osteoporosis of 16% and of osteopenia of 57% in women 50 years of age and older. We also found a higher prevalence of osteoporosis in women of the south east part of the county.
Collapse
|
39
|
Cifuentes L, Jorquera H, Aguirre E, Moreno F. [Paternity determination in cases of incest using multiallelic loci DNA polymorphisms]. Rev Med Chil 1996; 124:1307-13. [PMID: 9293094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The analysis of genetic markers in man allows to efficiently resolve cases of dubious paternity. Lately, the use of genetic markers derived from DNA analysis allows high exclusion probabilities. A particular case are those consultations whom the progenitors are closely related, in which the criteria to attribute paternity are modified. The present report explains the analysis methods and interpretation of results in situations of doubtful paternity in cases of incest between father and daughter, using monolocus DNA polymorphisms. The method is illustrated through the analysis of four cases seen at the Servicio Médico Legal of Santiago. To be able to determine paternity in these cases of incest, at least three multiallelic loci in which mother and son have different genotypes must be examined.
Collapse
Affiliation(s)
- L Cifuentes
- Departamento de Biología Celular y Genética, Facultad de Medicina, Universidad de Chile
| | | | | | | |
Collapse
|
40
|
Cordova JA, Aguirre E, Hernández A, Hidalgo V, Domínguez F, Durante I, Jesús R, Castillo O. Assessment and accreditation of Mexican medical schools. Med Educ 1996; 30:319-321. [PMID: 8949468 DOI: 10.1111/j.1365-2923.1996.tb00840.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
With the objective of evaluating and accrediting the quality of medical education in the country, the Mexican Association of Medical Schools initiated the National Programme for the Strengthening of the Quality of Medical Education (PNFCE). This programme led to the establishment of the National System of Accreditation. Medical school deans in Mexico determined the criteria for the evaluation of quality and its subsequent standards through a consensus process. The following 10 criteria resulted: general basis and educational objectives; government and institutional orientation; educational programme and academic structure; educational process assessment; students; teaching staff; institutional coherence; resources; clinical sites; and administration. Eighty-eight standards were developed in the instrument designed for the self-evaluation phase. The information resulting from the self-evaluation will be verified by a group of experts during a survey visit, which will be finalized with a report to serve as the basis for the decision to be made by the Accreditation Commission. The self-evaluation phase started in 1994. In 1996 four schools submitted their request for accreditation. As of July 1996, one survey visit has been completed and three more are programmed for the second half of the year.
Collapse
Affiliation(s)
- J A Cordova
- Mexican Association of Medical Schools, Mexico City
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Vio F, Salazar G, Yañez M, Pollastri A, Aguirre E, Albala C. Smoking and its effects on maternal body composition in late pregnancy. Eur J Clin Nutr 1995; 49:267-73. [PMID: 7796784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
OBJECTIVE To assess the possible impact of smoking on body composition at the 34-39 weeks of pregnancy, and its consequences on birth weight. SUBJECTS 31 smokers and 31 non-smokers matched by age, gestational age and percentage of standard weight (PSW). Smoking mothers had 5 cigarettes or more per day during the whole period of pregnancy and non-smoking mothers never smoked. METHODS A cross-sectional study was conducted in an urban Public Health Center. Anthropometry and the deuterium dilution technique were used to determine body composition. The statistical analysis used a t-test for matched pairs to assess significance of the means difference for each variable. RESULTS Suprailiac and subscapular skinfolds were found to be larger in non-smokers; this difference was significant for the suprailiac skinfold (P < 0.05). No significant difference was found in total body fat, total body water and fat-free mass obtained with the deuterium dilution technique, or FFM determined by anthropometry. Infants' birth weight was similar in the two groups of mothers. CONCLUSION These findings suggest that pregnancy does not modify the pattern of body fat distribution already present in smokers before conception. Infants' birth weight was similar in both groups, probably due to no difference in fat-free mass and body fat. The physiological effect of nicotine (e.g. on prolactin, micronutrients), seems to be clearer during lactation and infant growth.
Collapse
Affiliation(s)
- F Vio
- Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago
| | | | | | | | | | | |
Collapse
|
42
|
Villegas L, Aguirre E, Zavaleta A. [Effects of lyophilization on four biological activities of Bothrops atrox venom (Serpentes: Viperidae)]. REV BIOL TROP 1993; 41:851-3. [PMID: 7886256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Fresh venom was obtained by milking both sexes of adult Bothrops atrox snakes. Four biological activities were studied in both fresh and freeze dried venom: local hemorrhagic in guinea pig skin, proteolytic upon casein (caseinolytic), esterasic upon TAME and fibrinogen clotting activity. All activities were detected in fresh venom: Hemorrhagic (DHM = 0.93, DHR = 9.75 micrograms protein), caseinolytic (0.25 U kunitz/mg protein), esterasic (0.70 U/mg protein) and clotting activity (75.7 U NIH/mg protein). After freeze drying, all the biological activity of B. atrox venom enzymes decreased: hemorrhagic, caseinolytic and clotting activity in 50% and the esterasic activity only in 15%. Our results show that lyophylization decreases several important biological activities in snake venom related to a decrease in the venom enzymatic activities.
Collapse
Affiliation(s)
- L Villegas
- Depto. Académico de Ciencias Fisiológicas, Universidad Peruana Cayetano Heredia, A.P., Lima, Perú
| | | | | |
Collapse
|
43
|
Aguirre E, Benítez R, Youlton R, Carvallo P. [Molecular genetic study of a severe growth hormone deficiency in a Chilean family]. Rev Med Chil 1993; 121:982-6. [PMID: 7910700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The first and so far the only form of isolated growth hormone deficiency to accede to molecular genetic analysis is IGHD 1A, which has an autosomal recessive mode of inheritance. Several sizes of growth hormone gene deletions, ranging from 6.7 to 8.5 Kb are responsible for IGHD 1A. It has been reported that children with IGHD 1A have an initial good response to growth hormone treatment, followed by growth failure associated with the development of blocking antibodies against growth hormone. The effectiveness of treatment has been associated to the size of the gene deletion. We performed a molecular genetic analysis of the growth hormone locus, using Southern Blot and PCR techniques, to a 12 years old girl who fulfilled the criteria for IGHD 1A and her closer relatives. The results showed a 7 Kb deletion for the growth hormone gene in the girl and one of her brothers.
Collapse
Affiliation(s)
- E Aguirre
- Departamento de Bioquímica, Facultad de Medicina, Universidad de Chile, Santiago de Chile
| | | | | | | |
Collapse
|
44
|
Arévalo C, Herrmann F, Aguirre E, Vera J. [Hemolytic disease of the newborn due to ABO incompatibility. A predictive test]. Rev Med Chil 1992; 120:163-7. [PMID: 1340554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
A direct 2 stage enzymatic test and the direct anti gamma globulin test were used to predict hemolytic disease of the newborn. Maternal allo-antibodies were determined in cord blood of all newborns from April to June 1988. 0.25% bromelase was used for the 2 Stage Enzymatic Test and a polyspecific anti-gammaglobulin serum was used for the Anti Gamma Globulin Test. Of 618 newborns 97 had parental ABO heterospecificity. Maternal allo-antibodies were present in 20 cases (3.2%). 20 of 86 fullterm newborns developed jaundice presumably due to ABO incompatibility. Blood exchange was required in 6, while phototherapy was sufficient in the rest. The 2 Stage Enzymatic Test was positive in 20 of these cases and the Anti Gamma Globulin Test was positive in 10. Thus, these tests may be used to predict hemolytic disease of the newborn due to ABO incompatibility.
Collapse
Affiliation(s)
- C Arévalo
- Unidad Banco de Sangre, Instituto de Hematología Rodolfo Virchow. Valdivia, Chile
| | | | | | | |
Collapse
|
45
|
Carrasco E, López G, García de los Ríos M, Vargas N, Staab K, Guerrero M, Espinoza F, Aguirre E. [Incidence of insulin-dependent diabetes mellitus in the metropolitan region]. Rev Med Chil 1991; 119:709-14. [PMID: 1844378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
We used a retrospective search and confirmation method to establish the number of new cases of insulin dependent diabetes mellitus diagnosed between Jan 1, 1986 and Dec 31, 1989 in subjects under 15 years of age in the Metropolitan region of Chile. All hospitals and outpatient facilities of the National Health Service, other hospitals and private offices of endocrinologists and specialists in diabetes were surveyed, as well as the registry from the Juvenile Diabetes Foundation. A total of 115 cases, 52 in males and 63 in females were found, for an annual incidence of 1.69 and 2.15 per 100,000, respectively. Overall, the annual incidence rates were 2.22 in 1986, 1.22 in 1987 (p < 0.001), 2.13 in 1988 and 2.09 in 1989. A greater number of cases was diagnosed at age 4 in males and at age 12 in females (p < 0.001). The greater number of cases were diagnosed from June to August (winter) and the lowest in October (p < 0.001).
Collapse
Affiliation(s)
- E Carrasco
- Unidad de Diabetes y Nutrición, Facultad de Medicina, Universidad de Chile (División Occidente), Hospital San Juan de Dios, Santiago de Chile
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Infante C, Hurtado J, Salazar G, Pollastri A, Aguirre E, Vío F. The dose-to-mother method to measure milk intake in infants by deuterium dilution: a validation study. Eur J Clin Nutr 1991; 45:121-9. [PMID: 2065635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
A validation study of the dose-to-mother deuterium dilution method to measure breast-milk intake has been carried out on ten infants from a Nutrition Recovery Centre in Santiago, Chile. Formula milk labelled with exponentially decreasing doses of deuterium oxide represented milk from a 'pseudo mother' of these exclusively bottle-fed infants. Unlabelled formula represented milk from other sources. Deuterium levels in the infants' body water were measured on saliva samples by mass spectroscopy. The data were fitted in a two-compartment steady-state model of the mother-child system to estimate the flow of labelled water from the 'mother' to the infant and the 'mother' and infant's water elimination constants. A dose-to-child experiment was also carried out on each infant to determine the deuterium dilution space and total daily water intake. Total and labelled water flows from deuterium dilution were used to calculate total, labelled and unlabelled formula milk intakes which were compared to the same quantities measured by bottle weighing. Water elimination constants calculated from the dose-to-mother experiments underestimated by 17 per cent the initially set mother constant and overestimated by 21 per cent the infant constants calculated from the dose-to-child experiments. Rate constants, however, have little effect on the estimated water flows so that there was good agreement between values from deuterium dilution and from direct weighing. Mean (SD) total formula, labelled formula and unlabelled formula intakes were 865 (129) g/d, 417 (74) g/d and 448 (106) g/d, respectively, when measured by deuterium dilution, compared with 856 (116) g/d, 414 (71) g/d and 441 (68) g/d when measured by direct weighing. The mean per cent differences were 1.1 per cent, 0.7 per cent and 1.6 per cent and the mean absolute differences for individuals, 4.3 (1.9) per cent, 4.8 (3.1) per cent and 9.7 (6.6) per cent, respectively.
Collapse
Affiliation(s)
- C Infante
- Facultad de Ciencias, Universidad de Chile, Santiago
| | | | | | | | | | | |
Collapse
|
47
|
Aguirre E, Arsuaga JL, Bermúdez de Castro JM, Carbonell E, Ceballos M, Díez C, Enamorado J, Fernández-Jalvo Y, Gil E, Gracia A, Martín-Nájera A, Martínez I, Morales J, Ortega AI, Rosas A, Sánchez A, Sánchez B, Sesé C, Soto E, Torres TJ. The Atapuerca sites and the ibeas hominids. ACTA ACUST UNITED AC 1990. [DOI: 10.1007/bf02436474] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
48
|
Barros C, Jedlicki A, Bize I, Aguirre E. Relationship between the length of sperm preincubation and zona penetration in the golden hamster: A scanning electron microscopy study. ACTA ACUST UNITED AC 1984. [DOI: 10.1002/mrd.1120090104] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
49
|
Romero MI, Vargas S, Abara S, Abud A, Acevedo O, Acuña H, Aguirre L, Aguirre E, Aliste F, Allel L. [Pregnancy, delivery and newborn infants in adolescent mothers]. Rev Chil Pediatr 1983; 54:123-130. [PMID: 6647908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
50
|
Read-Martin CE, Read DW, Aguirre E, Collins D, Forbis RG, Khatri AP, Scarlett RJ. Australopithecine Scavenging and Human Evolution: An Approach From Faunal Analysis [and Comments and Reply]. Current Anthropology 1975. [DOI: 10.1086/201568] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|